Fact Sheet


The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, reimbursement, and manufacturing initiatives to advance this innovative and transformative sector, which includes cell therapies, gene therapies and tissue-based therapies. Early products to market have demonstrated profound, durable and potentially curative benefits that are already helping thousands of patients worldwide, many of whom have no other viable treatment options.

Hundreds of additional product candidates contribute to a robust pipeline of potentially life-changing regenerative medicines and advanced therapies. In its 11-year history, ARM has become the global voice of the sector, representing the interests of 380+ members worldwide, including small and large companies, academic research institutions, major medical centers and patient groups.


The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, reimbursement, and manufacturing initiatives to advance this innovative and transformative sector, which includes cell therapies, gene therapies and tissue-based therapies. Early products to market have demonstrated profound, durable and potentially curative benefits that are already helping thousands of patients worldwide, many of whom have no other viable treatment options.

Hundreds of additional product candidates contribute to a robust pipeline of potentially life-changing regenerative medicines and advanced therapies. In its 11-year history, ARM has become the global voice of the sector, representing the interests of 380+ members worldwide, including small and large companies, academic research institutions, major medical centers and patient groups.

What Is Regenerative Medicine?

Regenerative medicine includes gene therapies, cell therapies, and tissue-engineered products intended to augment, repair, replace, or regenerate organs, tissues, cells, genes, and metabolic processes in the body.

Regenerative medicine aims to alter the current practice of medicine by treating the root causes of disease and disorders.

The regenerative medicine and advanced therapies sector is creating transformative, durable treatments and potential cures for some of humankind’s most devastating diseases – many currently untreatable via conventional treatments – through the use of ground-breaking scientific discoveries and technologies.

 

ARM’s Multi-Stakeholder Membership

Diversity of Organizations (n=374) Diversity of Technology Focus (n=374)
Corporations (Revenue < $50M, <100 FTEs)

51%

Gene Therapy

24%

Corporations (Revenue < $50M, >100 FTEs)

14%

Cell Therapy

29%

Corporations (Revenue > $50M)

9%

Cell & Gene Therapy

5%

Non-Profit Institutions

18%

Tissue Engineering

8%

Academic

4%

CMOs and CROs

13%

Affiliates & Financial Institutions

5%

Service Providers

9%

Advocacy Organizations

6%

Research Organizations

4%

Medical Device

2%

ARM is a tax-exempt, social welfare organization as described by Internal Revenue Code (IRC) section 501(c)(4). As a 501(c)(4) organization, ARM is a not-for-profit organization, and operates to promote social welfare. To that end, seeking legislation germane to the ARM’s programs is a permissible means of attaining social welfare purposes, per section 501(c)(4) of the Internal Revenue Code (IRC).